|

Optimizing Bronchopulmonary Cancer Screening

RECRUITINGN/ASponsored by Institut Curie
Actively Recruiting
PhaseN/A
SponsorInstitut Curie
Started2025-01-17
Est. completion2032-01-17
Eligibility
Age50 Years – 74 Years
Healthy vol.Accepted

Summary

The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.

Eligibility

Age: 50 Years – 74 YearsHealthy volunteers accepted
Inclusion Criteria:

* Participant aged 50 to 74.
* Resident in the Île-de-France region.
* Active smoker or quit smoker for 10 years or less:

  1. more than 10 cigarettes a day for more than 30 years,
  2. more than 15 cigarettes a day for more than 25 years.
* The participant has been informed and has signed the consent form.
* Social Security System affiliation.
* Willingness to participate in a smoking cessation program, if currently smoking.

Exclusion Criteria:

* Active cancer or a history of cancer in remission for less than 5 years (except basal cell carcinoma of th skin or epithelioma in situ of the uterine cervix).
* Presence of symptoms suggestive of bronchopulmonary cancer. Participants with these symptoms require immediate diagnostic investigations and are therefore not eligible for screening.
* Weight \>= 140 kg.
* Severe comorbidity contraindicating therapeutic options or invasive thoracic diagnostic investigations.
* Inability to climb two flights of stairs without stopping.
* A thoracic CTscan performed within the previous year.
* Persons deprived of liberty or under guardianship.
* Impossibility to undergo the medical monitoring of the trial for geographical, social or psychological reasons.

Conditions3

Bronchopulmonary DiseaseCancerDiagnoses Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.